Welcome to ReadCrystal, where groundbreaking structural analysis technology drives our commitment to revolutionizing early-stage drug development. At ReadCrystal, we established a comprehensive platform for protein expression and purification, X-ray crystallography, cryo-electron microscopy single-particle analysis, MicroED, molecular interaction detection, and Fragment-Based Drug Discovery (FBDD). We are committed to offering all-in-one service for early-stage drug development.
Protein Expression and Purification Platform
X-ray Crystallography Platform
We provide a comprehensive service including protein crystallization screening and optimization, synchrotron X-ray diffraction data collection, and complete structural analysis.

Cryo-Electron Microscopy Single-Particle

Analysis Platform

We offer negative staining screening, cryo-conditioned sample screening, 200kV preliminary data collection, 300kV high-resolution data collection, data processing, and model building to ultimately obtain the structure of macromolecular proteins.
MicroED Platform
We provide services for cryo-sample preparation, three-dimensional electron diffraction data collection, and structural analysis.
Molecular Interaction Platform
We have a comprehensive molecular interaction detection platform capable of providing data on interactions between small molecules and proteins, protein-protein interactions, and nucleic acid-protein interactions, including parameters such as Kd (dissociation constant), Tm (melting temperature), and others.